摘要:
Disclosed is a composition for reducing the exudation of the serum proteins. More specifically, the composition of the present invention relates to a composition capable of improving conditions such as atopic dermatitis, atopic eczema, skin pruritus, atopic nasitis, atopic erythema or erythroderma, contact dermatitis, asthma, chronic obstructive pulmonary disease, etc. by reducing the exudation of the serum proteins in skin and mucosa.
摘要:
The present invention relates to a composition for relieving and treating burns and bedsores comprising the animal lung tissue extract as an active ingredient, wherein the composition of the present invention suggests that the protective effect of animal lung tissue extract and/or propionic acid on skin damage is related to not only inflammation inhibition but also regeneration and angiogenesis of fibrous tissues. It can be used as a therapeutic agent for these diseases by exhibiting industrially available effects related to the treatment of burns and bedsores.
摘要:
Disclosed is a composition for reducing the exudation of the serum proteins. More specifically, the composition of the present invention relates to a composition capable of improving conditions such as atopic dermatitis, atopic eczema, skin pruritus, atopic nasitis, atopic erythema or erythroderma, contact dermatitis, asthma, chronic obstructive pulmonary disease, etc. by reducing the exudation of the serum proteins in skin and mucosa.
摘要:
Disclosed is a composition for reducing the exudation of the serum proteins. More specifically, the composition of the present invention relates to a cosmetic composition comprising, as effective components, di-saturated phospholipids, calcium ions and an organic acid containing one or more carboxyl groups.
摘要:
Disclosed is a composition for reducing the exudation of the serum proteins. More specifically, the composition of the present invention relates to a composition capable of improving conditions such as atopic dermatitis, atopic eczema, skin pruritus, atopic nasitis, atopic erythema or erythroderma, contact dermatitis, asthma, chronic obstructive pulmonary disease, etc. by reducing the exudation of the serum proteins in skin and mucosa.